Purchase Order VA25812P0812
Award Date 12/22/11
Potential Completion Date 12/22/11
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Big Spring, TX 79720, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the Provant Therapy System, a proprietary medical device developed by Regenesis Biomedical Inc. The $7,203.90 firm fixed-price contract was awarded by the Department of Veterans Affairs (VA) through VA Integrated Service Network 17. The contract is for the supply and rental of the Provant Therapy System, which is indicated for the palliative treatment of post-operative pain and edema. The contract was awarded as a purchase order and is not associated with any...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a private medical technology company. The $7,055.10 firm-fixed-price purchase order is for the provision of the Provant Therapy System, a patented noninvasive regenerative medicine product developed by Regenesis Biomedical. The contract, which does not utilize any set-aside, is awarded against Regenesis Biomedical's GSA Schedule 65-II-A contract for medical equipment and supplies. The...
- This federal contract award is for the purchase of the Provant Therapy System from Regenesis Biomedical Inc., a medical technology company. The $4,820.98 firm fixed-price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) on December 28, 2010, with an ultimate completion date of January 28, 2011. The contract was awarded against Regenesis Biomedical's existing GSA Schedule 65-II-A contract for medical equipment and supplies, and did not utilize any set-aside designations....
- This federal contract award, valued at $4,820.98, was issued by the U.S. Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a private medical technology company, for the provision of the company's Provant Therapy System. The Provant Therapy System is a non-invasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract was awarded as a Firm Fixed Price purchase order and did not utilize any set-aside designations....
- This federal contract award to Regenesis Biomedical Inc. is for the procurement of the Provant Therapy System, a medical device indicated for the palliative treatment of post-operative pain and edema. The contract, valued at $5,066.00, was awarded by the U.S. Department of Veterans Affairs (VA) under a firm fixed-price purchase order. The contract has no set-aside designation. Based on the information provided, Regenesis Biomedical Inc. acts as the prime contractor, supplying its proprietary...
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $4,820.98 firm-fixed-price purchase order is for the company's Provant Therapy System, a noninvasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract has an ultimate completion date of May 8, 2011 and was awarded through Regenesis Biomedical's existing GSA Schedule...
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company, for the provision of the Provant Therapy System and related rental services. The $7,142.85 firm-fixed-price purchase order contract, awarded on February 2, 2011, with a completion date of March 2, 2011, was not set aside for any preference program. Regenesis Biomedical Inc. is the prime contractor and is providing its proprietary Provant...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company, for the provision of the Provant Therapy System, a patented medical device used for the palliative treatment of post-operative pain and edema. The contract, valued at $4,820.98, is a firm fixed-price purchase order with no set-aside designation. Regenesis Biomedical has provided the Provant Therapy System and related rental services to the...
- This is a federal contract award from the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a medical technology company. The $7,055.10 firm-fixed-price purchase order is for the company's Provant Therapy System, a non-invasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract has no set-aside designation and was awarded on December 16, 2010, with a completion date of January 16, 2011. Regenesis Biomedical, the...
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $4,820.98 firm fixed-price purchase order is for the Provant Therapy System, a noninvasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract has an ultimate completion date of January 20, 2011. Regenesis Biomedical has provided the Provant Therapy System and related rental...